PortfoliosLab logoPortfoliosLab logo
ABT vs. MMM
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ABT vs. MMM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Abbott Laboratories (ABT) and 3M Company (MMM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ABT achieves a -26.95% return, which is significantly lower than MMM's -2.97% return. Over the past 10 years, ABT has outperformed MMM with an annualized return of 11.01%, while MMM has yielded a comparatively lower 4.22% annualized return.


ABT

1D
-0.63%
1M
7.33%
YTD
-26.95%
6M
-25.03%
1Y
-30.87%
3Y*
-1.86%
5Y*
-1.83%
10Y*
11.01%

MMM

1D
0.06%
1M
7.92%
YTD
-2.97%
6M
-5.26%
1Y
7.72%
3Y*
26.44%
5Y*
1.64%
10Y*
4.22%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ABT vs. MMM - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ABT
Abbott Laboratories
-26.95%12.87%4.81%2.26%-20.68%30.53%28.04%22.08%29.06%52.03%
MMM
3M Company
-2.97%26.36%46.13%-3.33%-29.63%4.85%2.77%-4.29%-16.90%34.90%

Correlation

The correlation between ABT and MMM is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.05

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.29

Correlation (10Y)
Calculated over the trailing 10-year period

0.34

Correlation (All Time)
Calculated using the full available price history since Apr 7, 1983

0.35

Over the past year, the correlation between ABT and MMM has dropped to 0.05 - well below their long-term average of 0.35, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

ABT:

$158.10B

MMM:

$81.97B

EPS

ABT:

$3.59

MMM:

$5.17

PE Ratio

ABT:

25.21

MMM:

29.78

PS Ratio

ABT:

3.51

MMM:

3.32

PB Ratio

ABT:

2.39

MMM:

25.12

Total Revenue (TTM)

ABT:

$45.13B

MMM:

$25.02B

Gross Profit (TTM)

ABT:

$25.45B

MMM:

$9.89B

EBITDA (TTM)

ABT:

$10.80B

MMM:

$5.28B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ABT vs. MMM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABT
ABT Risk / Return Rank: 55
Overall Rank
ABT Sharpe Ratio Rank: 11
Sharpe Ratio Rank
ABT Sortino Ratio Rank: 44
Sortino Ratio Rank
ABT Omega Ratio Rank: 44
Omega Ratio Rank
ABT Calmar Ratio Rank: 1111
Calmar Ratio Rank
ABT Martin Ratio Rank: 22
Martin Ratio Rank

MMM
MMM Risk / Return Rank: 5050
Overall Rank
MMM Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
MMM Sortino Ratio Rank: 4747
Sortino Ratio Rank
MMM Omega Ratio Rank: 4545
Omega Ratio Rank
MMM Calmar Ratio Rank: 5252
Calmar Ratio Rank
MMM Martin Ratio Rank: 5353
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ABT vs. MMM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Abbott Laboratories (ABT) and 3M Company (MMM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ABTMMMDifference
Sharpe ratioReturn per unit of total volatility

-1.57

Sortino ratioReturn per unit of downside risk

-2.32

Omega ratioGain probability vs. loss probability

0.77

1.07

-0.30

Calmar ratioReturn relative to maximum drawdown

-0.79

0.41

-1.21

Martin ratioReturn relative to average drawdown

-1.79

0.92

-2.71

ABT vs. MMM - Sharpe Ratio Comparison

The current ABT Sharpe Ratio is -1.27, which is lower than the MMM Sharpe Ratio of 0.30. The chart below compares the historical Sharpe Ratios of ABT and MMM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ABTMMMDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-1.27

0.30

-1.57

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.08

0.06

-0.14

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.47

0.16

+0.31

Sharpe Ratio (All Time)

Calculated using the full available price history

0.49

0.34

+0.15

Drawdowns

ABT vs. MMM - Drawdown Comparison

The maximum ABT drawdown since its inception was -45.66%, smaller than the maximum MMM drawdown of -59.10%. Use the drawdown chart below to compare losses from any high point for ABT and MMM.


Loading charts...

Drawdown Indicators


ABTMMMDifference

Max Drawdown

Largest peak-to-trough decline

-45.66%

-59.10%

+13.44%

Max Drawdown (1Y)

Largest decline over 1 year

-38.99%

-18.77%

-20.22%

Max Drawdown (3Y)

Largest decline over 3 years

-39.64%

-22.87%

-16.77%

Max Drawdown (5Y)

Largest decline over 5 years

-39.64%

-53.41%

+13.77%

Max Drawdown (10Y)

Largest decline over 10 years

-39.64%

-59.10%

+19.46%

Current Drawdown

Current decline from peak

-33.84%

-11.04%

-22.80%

Average Drawdown

Average peak-to-trough decline

-10.83%

-16.11%

+5.28%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.23%

8.41%

+8.82%

Volatility

ABT vs. MMM - Volatility Comparison

Abbott Laboratories (ABT) has a higher volatility of 8.41% compared to 3M Company (MMM) at 6.60%. This indicates that ABT's price experiences larger fluctuations and is considered to be riskier than MMM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ABTMMMDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.41%

6.60%

+1.81%

Volatility (6M)

Calculated over the trailing 6-month period

19.45%

19.32%

+0.13%

Volatility (1Y)

Calculated over the trailing 1-year period

24.42%

26.01%

-1.59%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.04%

28.30%

-6.26%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.67%

26.54%

-2.87%

Dividends

ABT vs. MMM - Dividend Comparison

ABT's dividend yield for the trailing twelve months is around 2.70%, more than MMM's 1.96% yield.


PositionTTM20252024202320222021202020192018201720162015
ABT
Abbott Laboratories
2.70%1.88%1.95%1.85%1.71%1.28%1.32%1.47%1.55%1.86%2.71%2.14%
MMM
3M Company
1.96%1.82%16.27%5.49%4.97%3.33%3.36%3.26%2.86%2.00%2.49%2.72%

Financials

ABT vs. MMM - Financials Comparison

This section allows you to compare key financial metrics between Abbott Laboratories and 3M Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


6.00B7.00B8.00B9.00B10.00B11.00B12.00B20222023202420252026
11.16B
6.03B
(ABT) Total Revenue
(MMM) Total Revenue
Values in USD except per share items

ABT vs. MMM - Profitability Comparison

The chart below illustrates the profitability comparison between Abbott Laboratories and 3M Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

35.0%40.0%45.0%50.0%55.0%20222023202420252026
56.3%
40.7%
Portfolio components
ABT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported a gross profit of 6.28B and revenue of 11.16B. Therefore, the gross margin over that period was 56.3%.

MMM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, 3M Company reported a gross profit of 2.46B and revenue of 6.03B. Therefore, the gross margin over that period was 40.7%.

ABT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported an operating income of 1.84B and revenue of 11.16B, resulting in an operating margin of 16.5%.

MMM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, 3M Company reported an operating income of 1.40B and revenue of 6.03B, resulting in an operating margin of 23.2%.

ABT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported a net income of 1.08B and revenue of 11.16B, resulting in a net margin of 9.7%.

MMM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, 3M Company reported a net income of 653.00M and revenue of 6.03B, resulting in a net margin of 10.8%.


Frequently Asked Questions


ABT and MMM have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ABT has higher volatility (8.41%) compared to MMM (6.60%). In terms of maximum drawdown, ABT dropped -45.66% vs MMM's -59.10%.

MMM currently has the higher Sharpe Ratio (0.30 vs -1.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ABT and MMM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer